Government agency plans to shake down Big Pharma

|By:, SA News Editor

The Federal Trade Commission wants to extract least $1B from pharmaceutical companies for their alleged efforts to thwart the entry of cheaper generic drugs by paying generic makers to delay introducing their offerings.

Last June, the U.S. Supreme Court ruled that the FTC may legally challenge the deals.

(NVO) (PFE) (SNY) (ABBV) (JNJ) (RHHBY) (GSK) (AZN) (BMY)